2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacogenetics of SGLT2 Inhibitors Canagliflozin - Diabetes Mellitus, Gout | Phase 4 | Terminated | University of Maryland, Baltimore | 30 | 2015-06-01 | 2022-08-02 |
| the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia Febuxostat - Coronary Artery Disease | Phase 4 | Terminated | Yokohama City University Medical Center | 1 | 2014-10-01 | 2017-08-03 |
Coronary Artery Disease (1) · Diabetes Mellitus (1) · Gout (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Arthritis (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronary Disease (1) · Crystal Arthropathies (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Joint Diseases (1) · Metabolic Diseases (1)
Canagliflozin (1) · Febuxostat (1)
University of Maryland, Baltimore (1) · Yokohama City University Medical Center (1)
Japan (1)
Kiyoshi Hibi, MD (1) · Simeon I Taylor, MD, PhD (1)
R21DK105401 (1)